Evans John M.'s Form 4 filing
Beam Therapeutics Inc. (BEAM) · filed Jul 8, 2021
- Accession no.
- 0000899243-21-027903
- Filed
- Jul 8, 2021
- Trade date
- Jul 7, 2021
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 14 non-derivative transactions and 1 derivative transaction. Open-market sales total $2.70M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Evans John M.CIK 0001786304 | Director, Officer (CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 7, 2021 | Common Stock | MOption exerciseAcquired | +25,000 | $1.03 | +$25,750 | 1,046,525 | Direct | |
| Jul 7, 2021 | Common Stock | SSaleDisposed | −645 | $100.69F3 | −$64,945.05 | 1,045,880 | Direct | |
| Jul 7, 2021 | Common Stock | SSaleDisposed | −2,300 | $101.27F4 | −$232,921 | 1,043,580 | Direct | |
| Jul 7, 2021 | Common Stock | SSaleDisposed | −100 | $102.00 | −$10,200 | 1,043,480 | Direct | |
| Jul 7, 2021 | Common Stock | SSaleDisposed | −2,864 | $103.52F5 | −$296,481.28 | 1,040,616 | Direct | |
| Jul 7, 2021 | Common Stock | SSaleDisposed | −1,336 | $104.40F6 | −$139,478.4 | 1,039,280 | Direct | |
| Jul 7, 2021 | Common Stock | SSaleDisposed | −1,800 | $105.44F7 | −$189,792 | 1,037,480 | Direct | |
| Jul 7, 2021 | Common Stock | SSaleDisposed | −500 | $106.48F8 | −$53,240 | 1,036,980 | Direct | |
| Jul 7, 2021 | Common Stock | SSaleDisposed | −167 | $107.31F9 | −$17,920.77 | 1,036,813 | Direct | |
| Jul 7, 2021 | Common Stock | SSaleDisposed | −800 | $108.65F10 | −$86,920 | 1,036,013 | Direct | |
| Jul 7, 2021 | Common Stock | SSaleDisposed | −4,800 | $109.58F11 | −$525,984 | 1,031,213 | Direct | |
| Jul 7, 2021 | Common Stock | SSaleDisposed | −3,982 | $110.54F12 | −$440,170.28 | 1,027,231 | Direct | |
| Jul 7, 2021 | Common Stock | SSaleDisposed | −3,456 | $111.51F13 | −$385,378.56 | 1,023,775 | Direct | |
| Jul 7, 2021 | Common Stock | SSaleDisposed | −2,250 | $112.62F14 | −$253,395 | 1,021,525 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 7, 2021 | Common Stock | MOption exerciseDisposed | −25,000 | $0.00 | $0 | 371,345 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $100.25 to $100.99, inclusive.
Referenced by the price of 1 transaction in Table I.
- F4
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $101.00 to $101.85, inclusive.
Referenced by the price of 1 transaction in Table I.
- F5
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $103.21 to $103.96, inclusive.
Referenced by the price of 1 transaction in Table I.
- F6
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $104.00 to $104.96, inclusive.
Referenced by the price of 1 transaction in Table I.
- F7
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $105.02 to $105.98, inclusive.
Referenced by the price of 1 transaction in Table I.
- F8
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $106.12 to $106.77, inclusive.
Referenced by the price of 1 transaction in Table I.
- F9
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $107.29 to $107.33, inclusive.
Referenced by the price of 1 transaction in Table I.
- F10
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $108.32 to $108.99, inclusive.
Referenced by the price of 1 transaction in Table I.
- F11
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $109.01 to $109.98, inclusive.
Referenced by the price of 1 transaction in Table I.
- F12
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $110.04 to $110.99, inclusive.
Referenced by the price of 1 transaction in Table I.
- F13
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $111.04 to $111.99, inclusive.
Referenced by the price of 1 transaction in Table I.
- F14
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $112.00 to $112.99, inclusive.
Referenced by the price of 1 transaction in Table I.